---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-25-000132"
form_type: "8-K"
ticker: "BNGO"
cik: "0001411690"
company_name: "Bionano Genomics, Inc."
filed_at: "2025-01-03T23:59:59+00:00"
generated_at: "2026-05-28T13:56:13.482947+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Bionano Genomics amends convertible debentures, reduces near-term payments, conversion price to $0.27

## Summary
- Amendment defers December 2024 redemption; monthly payments cut from $1M to $500k for Jan-Jul 2025, then rise to $1.375M from Aug 2025.
- Conversion price reduced from $2.00 to $0.27; $15M principal convertible into 55.6M shares; 45.6M unregistered.
- Company issued 5M shares as consideration; forbears from redemption notices until July 31, 2025.
- Company to file registration statement for resale of shares by Jan 7, 2025.
- Canaccord Genuity acted as exclusive financial advisor.

## SEC filing metadata
- accession: 0001140361-25-000132
- form_type: 8-K
- ticker: BNGO
- cik: 0001411690
- company_name: Bionano Genomics, Inc.
- filed_at: 2025-01-03T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1411690/000114036125000132/0001140361-25-000132-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1411690/000114036125000132/ny20039922x1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-25-000132
- JSON: https://secwatch.observer/filing/0001140361-25-000132.json
- Plain text: https://secwatch.observer/filing/0001140361-25-000132.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.